Navigation Links
Sun Pharmaceutical Extends Tender Offer for Taro
Date:3/20/2009

MUMBAI, India, March 20 /PRNewswire/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced its subsidiary, Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the Expiration Date of the Tender Offer for the purchase of all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). The Offer will now expire at 5:00 p.m., New York City time, on Friday, April 3, 2009, unless further extended or earlier terminated. The Tender Offer was extended to comply with a continuing order issued by the Supreme Court of Israel temporarily prohibiting the closing of the Offer until the Supreme Court issues a decision on the appeal of the litigation commenced against Alkaloida and its affiliates by Taro and certain of its directors regarding the applicability of the special tender offer rules under the Israeli Companies Law to the Offer. The Tel-Aviv District Court had previously ruled in favor of Sun that a special tender offer was not required.

The mediation process between the parties to the litigation and the Levitt and Moros families, entered into at the recommendation of the Supreme Court, is ongoing. If the temporary order remains in effect on April 3, 2009, Sun expects to extend the Offer while the temporary order remains outstanding.

The Offer was commenced on June 30, 2008 in order to comply with the terms of the Option Agreement between Alkaloida and the controlling shareholders of Taro. Alkaloida exercised its options to acquire shares of Taro from the controlling shareholders on June 25, 2008. The Option Agreement required Alkaloida, promptly after exercising the options, to commence a tender offer at USD 7.75 per Ordinary Share of Taro held by other shareholders. The Offer had previously been scheduled to expire at 5:00 p.m., New York City time, on Friday, March 20, 2009. As of 5:00 p.m., New York City time, on March
'/>"/>

SOURCE Sun Pharmaceutical Industries, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...esearch and surveillance urged for at-risk patient...ws) -- Some childhood cancers, particularly Ewing ...the risk of late recurrence, U.S. researchers have...12,795 five-year survivors of the most common pedi...ancer Survivor Study. , The researchers found t...
(Date:12/4/2009)..., SEATTLE Cholesterol-lowering drugs known as st...he U.S. Now a new study by researchers at Fred Hut...ins may protect stem cell transplant patients from...-saving cancer therapy: graft-versus-host disease,...first edition of the journal Blood . , In a retr...
(Date:12/4/2009)...rmed with knowledge of risks, many hesitate to tak...IDAY, Dec. 4 (HealthDay News) -- Worries about sid... American women at high risk for breast cancer are... disease, a new study finds. , In an effort to ...ifen, researchers at the University of Michigan Co...
(Date:12/4/2009)... TrekDesk Inventor Showcas... (Vocus) December 4, 2009 -- A... an invention proven to help individuals lose weig...and boost productivity will be showcasing the prod... the Civic Center Gallery., , , , , TrekDesk has...
(Date:12/4/2009)..., , JACKSONVILLE, Fla., Dec. 4 /PRNe...s received awards for their work in improving the ...he Blue Foundation for a Healthy Florida,s 2009 Sa... Florida,s only statewide award that recognizes an...cellence in addressing health disparities within t...
Breaking Medicine News(10 mins):Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
...aces such as park and lawns in their neighborhoods..., said a US study. Researchers studied 7,334...he US and used body mass index to determine which ...ores, and convenience stores around each child's h...
...golf swing could lie in your big toe. Or your heel...erican College// of Foot and Ankle Surgeons (ACFAS...likely to cause pain that can ruin your golf swing...oes not require surgery. The three most common p...
...tration ordered the makers of ADHD drugs to indica... the significant// ones being psychiatric and card...of the FDA’s Center for Drug Evaluation and Resear...d that FDA is working in tandem with drug manufact...
...r and intentionally reminisce about that shared ex...tionship// than couples who don’t have that reserv...h by an Appalachian State University psychology pr... and Emotion. Bazzini, a social psychologist...
...ecome impotent after prostate cancer surgery may f...rve grafts into the penis,// which assists in rest...ew report by researchers. These findings cam...atment for prostate cancer. Dr. Fernando P....
...ho served for 30 years as the director of the John...ored// by the Saudi Arabian-based King Faisal Foun...tate cancer research. Prince Khalid Al-Faisa...t an awards ceremony in Riyadh on Jan. 16. Walsh, ...
Other Medicine News:Health News:Foot Pain Ruining Your Golf Swing? 2Health News:Researcher Studies Benefits of Reminiscing About Laughter 2Health News:Patrick Walsh Wins International Medicine Prize 2
(Date:12/4/2009)...O, Calif., Dec. 4 Suneva Medical, ... today announced the appointment of Philip Ranker ... this role, Mr. Ranker will lead all Suneva Medica... finance, accounting, IT, IR, administration and h...,s senior management team. ,, "One of my key o...
(Date:12/4/2009)...TOWN, N.Y., Dec. 4 Bayer Diabetes ... of Bayer,s "Express Your Simple Win Creativity Co...d the winning video entries submitted by children ...rize is an in-person meeting today with Nick. ,...k, are: Caleb, age 6, from Danbury, CT, who dreams...
(Date:12/4/2009)... N.J., Dec. 4 Depression, anxiety ...ractivity Disorder (ADHD), sleep disorder and migr...o occur more often in people who said they had bee...epilepsy diagnosis, according to a survey of appro...Findings from " CNS-Related Comorbidities in Indiv...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 1METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis 28SPPS 29 12714 2Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 1Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism 49543 2Painkillers May Be Good for the Prostate 49540 1Painkillers May Be Good for the Prostate 49540 2Painkillers May Be Good for the Prostate 49540 3
...alth ("Radius") announced today that it has raised...onal financing round, increasing total Series C in...sed since the company,s inception to $106.5 millio...ed in the financing, led by MPM Bio IV NVS Strateg...ust, HealthCare Ventures, Oxford Bioscience Partne...
...e Corporation,researcher, Dan Tinker, presented ev...erence in Washington, DC this week indicating that... computerized brain plasticity-based,Brain Fitness...auditory and,language systems. The exercises are ...ition by improving speed and accuracy of informati...
Other Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2
Millennium 2000 Microplate Shaker Incubator
...ACSCalibur is the only four-color, automated bench...alysis and cell sorting. Designed specifically to ...bur system offers software instrument control, aut...with maximum ease and productivity. FACSCalibur is...
...ltracompact high end desktop multilaser flow cytom... of cell analysis and absolute counting. The CyFlo...ide scatter signals in combination with up to 13 f... can perform in a wide variety of measurements. Re...
Coulter EPICS XL
Medicine Products: